Profile change history

What changed for Bivalirudin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Bivalirudin identity.

78Total events
78Record additions
0Version changes
19Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 78 connected records →

Showing the latest 78 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00043940

PeptideScanner retained ClinicalTrials.gov record NCT00043940 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-09-16, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
September 16, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00073580

PeptideScanner retained ClinicalTrials.gov record NCT00073580 at 2026-11-15T21:58:19.888Z. Its registry update date was 2018-11-30, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
November 30, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00073593

PeptideScanner retained ClinicalTrials.gov record NCT00073593 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
November 10, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00079586

PeptideScanner retained ClinicalTrials.gov record NCT00079586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-01-05, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
January 5, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00262054

PeptideScanner retained ClinicalTrials.gov record NCT00262054 at 2026-11-15T21:58:19.888Z. Its registry update date was 2010-03-15, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
March 15, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00373451

PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 8, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00433966

PeptideScanner retained ClinicalTrials.gov record NCT00433966 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-12-04, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
December 4, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00448461

PeptideScanner retained ClinicalTrials.gov record NCT00448461 at 2026-11-15T21:58:19.888Z. Its registry update date was 2009-02-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
February 10, 2009
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00503126

PeptideScanner retained ClinicalTrials.gov record NCT00503126 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
November 10, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00616460

PeptideScanner retained ClinicalTrials.gov record NCT00616460 at 2026-11-15T21:58:19.888Z. Its registry update date was 2015-06-12, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
June 12, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00812370

PeptideScanner retained ClinicalTrials.gov record NCT00812370 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-07-15, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
July 15, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01087723

PeptideScanner retained ClinicalTrials.gov record NCT01087723 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-02-12, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
February 12, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01465503

PeptideScanner retained ClinicalTrials.gov record NCT01465503 at 2026-11-15T21:58:19.888Z. Its registry update date was 2014-04-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
April 8, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01519518

PeptideScanner retained ClinicalTrials.gov record NCT01519518 at 2026-11-15T21:58:19.888Z. Its registry update date was 2015-05-13, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 13, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01651780

PeptideScanner retained ClinicalTrials.gov record NCT01651780 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-04-07, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
April 7, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01848899

PeptideScanner retained ClinicalTrials.gov record NCT01848899 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02311231

PeptideScanner retained ClinicalTrials.gov record NCT02311231 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-05-19, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 19, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02384070

PeptideScanner retained ClinicalTrials.gov record NCT02384070 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-02-03, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
February 3, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03318393

PeptideScanner retained ClinicalTrials.gov record NCT03318393 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-01-31, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
January 31, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03532399

PeptideScanner retained ClinicalTrials.gov record NCT03532399 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
July 2, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03537586

PeptideScanner retained ClinicalTrials.gov record NCT03537586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
November 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03588611

PeptideScanner retained ClinicalTrials.gov record NCT03588611 at 2026-11-15T21:58:19.888Z. Its registry update date was 2021-08-09, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
August 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03664180

PeptideScanner retained ClinicalTrials.gov record NCT03664180 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-05-03, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 3, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03822975

PeptideScanner retained ClinicalTrials.gov record NCT03822975 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-08-27, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
August 27, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04278404

PeptideScanner retained ClinicalTrials.gov record NCT04278404 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
August 21, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05959252

PeptideScanner retained ClinicalTrials.gov record NCT05959252 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 8, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05984537

PeptideScanner retained ClinicalTrials.gov record NCT05984537 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-08-12, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
August 12, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06080074

PeptideScanner retained ClinicalTrials.gov record NCT06080074 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
August 10, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06275555

PeptideScanner retained ClinicalTrials.gov record NCT06275555 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06861374

PeptideScanner retained ClinicalTrials.gov record NCT06861374 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-03-06, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
March 6, 2025
Evidence lane
Clinical trials
Record added

Federal Register notice 2010-31583

The Federal Register published notice 2010-31583, attributed to FDA and its parent HHS department, on 2010-12-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ANGIOMAX,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
December 16, 2010
Evidence lane
Regulatory
Record added

Federal Register notice 2023-19013

The Federal Register published notice 2023-19013, attributed to FDA and its parent HHS department, on 2023-09-05. Its official title is “Merck Sharp & Dohme LLC, et al.; Withdrawal of Approval of 35 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2025-18453

The Federal Register published notice 2025-18453, attributed to FDA and its parent HHS department, on 2025-09-24. Its official title is “Elite Laboratories, Inc., et al.; Withdrawal of Approval of 72 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
September 24, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 98-25360

The Federal Register published notice 98-25360, attributed to FDA and its parent HHS department, on 1998-09-23. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
September 23, 1998
Evidence lane
Regulatory
Record added

Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.

PubMed lists PMID 29461391 in Anesthesia and analgesia as Journal Article, Review, with publication-date metadata of 2019-01 (month precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials.

PubMed lists PMID 31241442 in Cardiovascular & hematological disorders drug targets as Journal Article, Systematic Review, with publication-date metadata of 2020 (year precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 18, 2021
Evidence lane
Literature metadata
Record added

Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, a Recently Developed Generic of Bivalirudin.

PubMed lists PMID 31396727 in Pharmaceutical research as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2019-08-08 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 25, 2020
Evidence lane
Literature metadata
Record added

Role of Bivalirudin for Anticoagulation in Adult Perioperative Cardiothoracic Practice.

PubMed lists PMID 31521492 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2019-08-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 31, 2022
Evidence lane
Literature metadata
Record added

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.

PubMed lists PMID 31820428 in Thrombosis and haemostasis as Comparative Study, Letter, Systematic Review, with publication-date metadata of 2019-12-09 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 24, 2024
Evidence lane
Literature metadata
Record added

Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.

PubMed lists PMID 32091668 in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-02-24 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 9, 2021
Evidence lane
Literature metadata
Record added

The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite.

PubMed lists PMID 32127273 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2020-01-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 2, 2021
Evidence lane
Literature metadata
Record added

Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.

PubMed lists PMID 32216471 in Circulation. Cardiovascular interventions as Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2020
Evidence lane
Literature metadata
Record added

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support.

PubMed lists PMID 33174088 in American journal of cardiovascular drugs : drugs, devices, and other interventions as Journal Article, Review, with publication-date metadata of 2020-11-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 14, 2021
Evidence lane
Literature metadata
Record added

Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.

PubMed lists PMID 34491323 in European heart journal. Acute cardiovascular care as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2021-12-18 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 21, 2021
Evidence lane
Literature metadata
Record added

Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.

PubMed lists PMID 35007937 in Thrombosis research as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2021-12-31 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 1, 2022
Evidence lane
Literature metadata
Record added

Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis.

PubMed lists PMID 35065202 in Pharmacological research as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2022-01-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta-analysis.

PubMed lists PMID 35098565 in British journal of clinical pharmacology as Journal Article, Meta-Analysis, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-14 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.

PubMed lists PMID 35616224 in Perfusion as Journal Article, Meta-Analysis, with publication-date metadata of 2022-05-26 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin in pediatric extracorporeal membrane oxygenation.

PubMed lists PMID 35634698 in Current opinion in pediatrics as Journal Article, Review, with publication-date metadata of 2022-06-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 7, 2022
Evidence lane
Literature metadata
Record added

Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation.

PubMed lists PMID 36194483 in ASAIO journal (American Society for Artificial Internal Organs : 1992) as Systematic Review, Meta-Analysis, Journal Article, with publication-date metadata of 2022-04-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 18, 2023
Evidence lane
Literature metadata
Record added

Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.

PubMed lists PMID 36355803 in ASAIO journal (American Society for Artificial Internal Organs : 1992) as Meta-Analysis, Systematic Review, Journal Article, with publication-date metadata of 2022-11-09 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane Oxygenation.

PubMed lists PMID 36449392 in Journal of pharmacy practice as Meta-Analysis, Journal Article, with publication-date metadata of 2022-11-30 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.

PubMed lists PMID 36999064 in Frontiers in medicine as Systematic Review, Journal Article, with publication-date metadata of 2023-03-14 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 1, 2023
Evidence lane
Literature metadata
Record added

Is it time to switch to bivalirudin for ECMO anticoagulation?

PubMed lists PMID 37671395 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 7, 2023
Evidence lane
Literature metadata
Record added

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.

PubMed lists PMID 37746717 in Circulation as Meta-Analysis, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-09-25 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 7, 2023
Evidence lane
Literature metadata
Record added

Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis.

PubMed lists PMID 37865864 in Coronary artery disease as Meta-Analysis, Journal Article, with publication-date metadata of 2023-09-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery.

PubMed lists PMID 38084653 in Perfusion as Journal Article, Review, with publication-date metadata of 2023-12-12 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin in Extracorporeal Membrane Oxygenation.

PubMed lists PMID 39259286 in Journal of cardiovascular pharmacology as Journal Article, Review, with publication-date metadata of 2024-12-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.

PubMed lists PMID 39334129 in BMC medicine as Journal Article, Randomized Controlled Trial, Comparative Study, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-09-27 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2024
Evidence lane
Literature metadata
Record added

Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.

PubMed lists PMID 39585174 in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies as Journal Article, Randomized Controlled Trial, Comparative Study, with publication-date metadata of 2024-11-25 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial.

PubMed lists PMID 40436723 in Cardiovascular revascularization medicine : including molecular interventions as Journal Article, Comparative Study, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2025-05-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 22, 2026
Evidence lane
Literature metadata
Record added

BMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis.

PubMed lists PMID 41029353 in BMC medicine as Journal Article, Randomized Controlled Trial, Comparative Study, with publication-date metadata of 2025-09-30 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 24, 2025
Evidence lane
Literature metadata
Record added

Bivalirudin as an Alternative to Heparin in Pediatric Cardiac Procedures: Evidence, Challenges, and Future Directions.

PubMed lists PMID 42602128 in Sage open pediatrics as Journal Article, Review, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 16, 2026
Evidence lane
Literature metadata
Record added

Bivalirudin Versus Heparin and Protamine in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.

PubMed lists PMID 42862663 in Annals of cardiac anaesthesia as Journal Article, Systematic Review, Meta-Analysis, Comparative Study, with publication-date metadata of 2026-10-12 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 8, 2026
Evidence lane
Literature metadata